Please assess the completion status of the following clinical trial:

Trial Title: Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Antibody Mediated Kidney Graft Rejection (ABMR)

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Recipients of a renal allograft, male and female patients age \>18~* The eGF\>20 ml/min/1.73 m2,~* Renal biopsy Criteria: chronic active ABMR.~* Written informed consent, compliant with local regulations.~Exclusion Criteria:~* Recipients of multiple organs.~* Pregnant women.~* Malignant disease in last 5 years~* Active autoimmune disease~* Active infection including hepatitis B, hepatitis C, HIV, or tuberculosis~* Evidence of congestive cardiac failure and/or acute coronary syndrome in past 6 months.~* Evidence of liver disease~* Inadequate compliance to treatment.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Historic control (Type: NO_INTERVENTION): historic cohort of patients with ABMR treated with standard of care therapy
- MSC transplantation (Type: EXPERIMENTAL): patients with ABMR treated with MSC transplantation

Based on this trial design, predict the completion outcome and termination type (if applicable).